Brief: Nextcell Pharma Q3 Pre-Tax Loss Widens To SEK 4.8 Mln
31/07/2020 07:36
July 31 (Reuters) - NextCell Pharma AB NXTCL.ST :
* Q3 OPERATING INCOME AMOUNTED TO SEK 750 512 (863 258).
* Q3 PRE-TAX LOSS SEK 4.8 MILLION VERSUS LOSS SEK 4.6
MILLION YEAR
AGO
Source text for Eikon: ID:nWkr2cQWNl
Further company coverage: NXTCL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln